Ameriprise
IMNM icon

Ameriprise’s Immunome IMNM Stock Holding History

Ameriprise’s Portfolio IMNM Stock Details IMNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.82M Buy
132,906
+3,391
+3% +$72.6K ﹤0.01% 2896
2026
Q1 		$2.83M Sell
129,515
-61,047
-32% -$1.36M ﹤0.01% 2788
2025
Q4 		$4.09M Buy
+190,562
New +$3.34M ﹤0.01% 2579
2024
Q4 		– Sell
-336,565
Closed -$4.92M – 4119
2024
Q3 		$4.92M Buy
336,565
+83,653
+33% +$1.19M ﹤0.01% 2386
2024
Q2 		$3.06M Sell
252,912
-10,957
-4% -$171K ﹤0.01% 2643
2024
Q1 		$6.51M Buy
+263,869
New +$5.35M ﹤0.01% 2162

Other funds holding IMNM

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $345M AUM 134.64% 1-Year Est. Return

Ameriprise's IMNM Position: Q2 2026 in Review

Ameriprise increased its Immunome (IMNM) stake by 2.6% in Q2 2026, buying an estimated $72.6K and bringing the position to 132,906 shares worth $2.82M. The position accounts for ﹤0.01% of the portfolio, ranked #2896.

Ameriprise first reported a position in IMNM in Q1 2024 and has held it in 6 quarters since. The position peaked at $6.51M in Q1 2024. 202 funds tracked by Wall St. Rank hold IMNM as of Q2 2026.

  • Ameriprise held 132,906 shares of Immunome worth $2.82M as of Q2 2026.
  • Ameriprise bought 3,391 Immunome shares in Q2 2026, an estimated $72.6K.
  • Immunome made up ﹤0.01% of Ameriprise's portfolio in Q2 2026, its #2896 holding.
  • Ameriprise first reported a position in Immunome in Q1 2024 and has held it in 6 quarters since.
  • Ameriprise's Immunome position peaked at $6.51M in Q1 2024.
  • 202 funds tracked by Wall St. Rank held Immunome as of Q2 2026.

Based on Ameriprise's 13F filing for Q2 2026, filed 14 Aug 2026.